1. Iatrogenic loss of superficial upper extremity veins from intravenous fluid administration or multiple cutdowns.
Creation of a successful primary arteriovenous fis-
tula may also be difficult in patients with nutritional problems. In obese individuals, despite good arterialization of veins, repetitive venepuncture may be difficult; while in severe cachexia, venepuncture, though technically easy, leads to subcutaneous hemorrhage because of lack of elastic strength of tissue, resulting in early failure of angioaccess.
Self-inflicted loss of veins in heroin addicts often
precludes the construction of a direct arteriovenous fistula.
4. Another group of patients in whom it is difficult to create a primary arteriovenous fistula are those with severe arterial disease, as seen in lonstanding diabetes mellitus, arteriosclerosis, and other collagen diseases.
5. Failure of a primary arteriovenous fistula occurs in many patients because of thrombosis, infection, trauma from dialysis needles, and progressive vascular disease. Also, repeated construction of new fistulas will systematically deplete conventional access sites in long-surviving hemodialysis patients.
6. An additional factor shortening the life-span of the vascular access is the hypercoagulability reported in maintenance hemodialysis patients (4) .
Secondary methods for vascular access are required when primary vascular access is precluded from the start by the factors listed above. Secondary vascular access has a high incidence of complications and failure, but is nonetheless justified by the absolute need for dialysis (5) .
Initial reports of new procedures tend to be enthusiastic, but eventually complications become apparent. This would explain the introduction of the following techniques, some of which have discarded: saphenous vein autografts (3, 6) , modified bovine arterial heterografts (3, 7, 8,) . Dacron velour grafts (7, 8) , Sparks mandril grafts (9) , expanded polytetrafluoraethylene (PTFE) grafts (10, 11) , modified human umbilical cord vein grafts (12) , and the Thomas shunt (13) .
Unfortunately, no ideal material exists, and secondary vascular access procedures have many problems. Autogenous sephenous vein graft have limited availability, and a tendency for the vein graft to develop fibrous stenosis (2, 3, 5, 6, 10) . Bovine graft have a high rate of infection, which may lead to graft disruption and brisk hemorrage (2, 3, 5, 6, 7, 8) .
There is also a high incidence of runoff stenosis from intimal hyperplasia. The Dacron graft is prone to the same complications as the bovine graft, but may be more resistant to infection (7, 8) .
The use of the Sparks mandril graft has been limited by the high rate of pseudoaneurysm formation, and by intimal proliferation and thrombosis (3, 9, 11) .
Recently expanded PTFE has gained wider acceptance because of graft availability, good handling characteristics, and incorporation to host tissues; however" intimal hyperplasia at the venous end is a major factor in decreasing graft survival (5, 10) .
The use of modified umbilical vein grafts has been somewhat limited, but similar problems appear to exist (2, 12) .
The hyperplastic response in the vessels adyacent to an anastomosis constitues a major obstacle to grafting small vessels.
As this phenomenon has also been observed in arterial bypass surgery, it appears that host factors are as difficult to overcome as is the problem of achieving an ideal graft.
A modification of the PTFE graft has been developed recently using an implantable device for needle insertion (15) . While this appears to reduce infectious complications, the hyperplastic response remains.
When no appropriate vessels in the extremities are available, specialized access techniques can be tried. These include superficialization of the femoral artery (16) , the use of an arterial jump graft (17), the insertion of a graft between the axiliary artery and vein, or between the brachial artery and internal jugular vein (18) , or the use of a deep inferior epigastric arteriovenous shunt (19) . At the present time these are procedures of the last resort, and little information is available about their long-term viability.
Clearly the challenge of secondary vascular access remains unsolved. As more patients are undergoing hemodialysis with constant attrition or lack of primary sites, the need for secondary vascular access will in-crease. Continuous ambulatory peritoneal dialysis (CAPD) may present a partial solution when vascular access has become a major problem. Yet peritonitis remains a major complication of this form of treatment, which is certainly not suitable for all patients with failed access (20) . This need should stimulate the search for better graft and techniques.
